Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population
for
Kidney Injury
Location: Boston MA, Denver CO
Sponsor: BioPorto Diagnostics
Sex: All
Age: 18+
Code: NCT03057457
Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Boston MA, New Haven CT, New York NY, Morristown NJ,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase 3, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Detroit MI,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase 1, Phase 2, Recruiting
The Role of Wearable Devices in Predicting and Detecting Complications and Adverse Events
for
Recovery, Treatment Complication
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT04824066
Recruiting
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
for
Depression, Brain Injuries, Traumatic
Location: Boston MA, Charlestown MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 64
Code: NCT04400266
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
for
Solid Tumors
Location: Boston MA, Montreal, Toronto, Durham NC, Atlanta GA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05203172
Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase 3, Recruiting
Incremental Hemodialysis: The TwoPlus Trial
for
End-Stage Kidney Disease
Location: Boston MA, Queens NY, New York NY, Baltimore MD,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT05828823
Recruiting
Initial Resuscitation for Acute Kidney Injury in Cirrhosis